Bio-Rad LaboratoriesBIO
紐約證券 · USD
261.33
-8.56
(-3.17%)
盤中 03/13 01:18 (UTC+8)
03/13 01:18 (UTC+8)
Bio-Rad LaboratoriesBIO
261.33
-8.56
(-3.17%)
財務數據
損益表
- 6.32
- 6.81
- 6.11
- 6.38
- 6.50
- 6.68
- 5.85
- 6.52
- 6.53
- 6.93
- -7.19
- 7.76
- -10.33
- 4.53
- 1.76
- 2.74
- -12.30
- 11.31
- 0.21
- 6.16
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 693,200 | 653,000 | 651,600 | 585,400 | 667,500 | 649,729 | 638,496 | 610,820 | 681,184 | 632,124 |
營業成本 | 348,000 | 309,600 | 306,300 | 279,400 | 325,600 | 293,826 | 283,311 | 284,854 | 314,821 | 296,441 |
營業毛利 | 345,200 | 343,400 | 345,300 | 306,000 | 341,900 | 355,903 | 355,185 | 325,966 | 366,363 | 335,683 |
營業費用 | 464,100 | 278,100 | 268,200 | - | 283,600 | 291,437 | - | - | 271,046 | 244,734 |
研發費用 | 70,300 | 71,300 | 60,500 | 73,500 | 79,600 | 90,997 | 58,879 | 66,375 | 63,899 | 43,535 |
推銷及管理費用 | 221,000 | 206,800 | 207,700 | 208,800 | 204,000 | 200,440 | 194,702 | 214,883 | 207,147 | 201,199 |
非經常性項目費用 | 172,800 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -118,900 | 65,300 | 77,100 | 23,700 | 58,300 | 64,466 | 101,604 | 44,708 | 95,317 | 90,949 |
其他收入及費用 | 1,060,200 | -484,100 | 349,500 | 71,700 | -955,000 | 809,328 | -2,875,666 | 458,647 | 345,436 | 58,551 |
利息費用 | 12,100 | 12,300 | 12,600 | 12,000 | 12,200 | 12,174 | 12,241 | 12,277 | 12,361 | 12,398 |
稅前純益 | 929,200 | -431,100 | 414,000 | 83,400 | -908,900 | 861,620 | -2,786,303 | 491,078 | 428,392 | 137,102 |
所得稅 | 209,200 | -89,200 | 96,200 | 19,400 | -193,100 | 208,448 | -620,833 | 107,162 | 78,684 | 30,845 |
稅後純益 | 720,000 | -341,900 | 317,800 | 64,000 | -715,800 | 653,172 | -2,165,470 | 383,916 | 349,708 | 106,257 |
基本每股稅後盈餘(元) | 26.69 | -12.70 | 11.67 | 2.29 | -25.57 | 23.37 | -76.26 | 13.46 | - | 3.65 |
稀釋每股稅後盈餘(元) | 26.39 | -12.38 | 11.55 | 2.29 | -25.47 | 22.72 | -76.06 | 13.45 | 11.81 | 3.46 |
基本平均股數(千股) | 26976.00 | 26923.00 | 27226.00 | 27941.00 | 27997.00 | 27949.00 | 28395.00 | 28518.00 | - | 29102.00 |
稀釋平均股數(千股) | 27012.00 | 26923.00 | 27228.00 | 27955.00 | 27997.00 | 27985.00 | 28395.00 | 28537.00 | - | 29223.00 |
還原基本每股稅後盈餘(元) | 26.69 | -12.70 | 11.67 | 2.29 | -25.57 | 23.37 | -76.26 | 13.46 | - | 3.65 |
還原稀釋每股稅後盈餘(元) | 26.39 | -12.38 | 11.55 | 2.29 | -25.47 | 22.72 | -76.06 | 13.45 | 11.81 | 3.46 |
還原基本平均股數(千股) | 26,976 | 26,923 | 27,226 | 27,941 | 27,997 | 27,949 | 28,395 | 28,518 | - | 29,102 |
還原稀釋平均股數(千股) | 27,012 | 26,923 | 27,228 | 27,955 | 27,997 | 27,985 | 28,395 | 28,537 | - | 29,223 |
EBITDA(千元) | 941,300 | -418,800 | 426,600 | 95,400 | -896,700 | 873,794 | -2,774,062 | 503,355 | 440,753 | 149,500 |